Sign Up to Receive Your Personalised Learning Resources
Start Learning
Kim Benstead, European Cancer Summit, 2022: Technical advances in cancer training in Europe
John Mascarenhas, ASH 2022: Treatment challenges in myelofibrosis and severe thrombocytopenia and the rationale for the use of pacritinib
How can real-world evidence guide the management of elderly and frail patients with multiple myeloma?
Facing clinical challenges associated with paroxysmal nocturnal haemoglobinuria
Mark Lawler, European Cancer Summit 2022: The ECO-ASCO Special Network
Current and emerging treatments for chronic myeloid leukemia: What have we learnt from EHA Hybrid Conference 2022?
Massimo Breccia, ASH 2022: The limitations of tyrosine kinase inhibitors in chronic myeloid leukaemia and approval status of asciminib
Fred Hirsch, ELCC 2022: Selecting Patients with Newly Diagnosed NSCLC for Biomarker Testing
Matthew Goetz, ESMO 2022: MONARCH 3 trial – Interim overall survival results of abemaciclib + NSAI in patients with HR+, HER2- advanced breast cancer
Professor Isabel Rubio: Optimizing Surgical Oncology in Cancer Care in Europe
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Advances and Future Goals in Acute Myeloid Leukaemia Therapy
View
Ajay Aggarwal, European Cancer Summit 2022: Ensuring a better future for young cancer professionals
View
Fred Saad, ESMO 2022: Highlights in prostate cancer – Phase 3 trials in the STAMPEDE platform protocol
View
World Cancer Day 2023: Unite voices and take action
View
The Evolving Therapeutic Landscape and Role of Enfortumab Vedotin in Advanced Urothelial Carcinoma: A Systematic Review
View
Sudeep Gupta, SABCS 2022: Addition of platinum to neoadjuvant chemotherapy in patients with triple-negative breast cancer: A phase III randomized controlled trial
View
Lena Sharp: PrEvCan – A cancer prevention campaign from the European Oncology Nurses Society
View
Jennifer Brown, ASH 2022: Zanubrutinib for patients with relapsed/refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma, ALPINE (phase III) results
View
John Mascarenhas, ASH 2022: Treatment challenges in myelofibrosis and severe thrombocytopenia and the rationale for the use of pacritinib
View
Eric Winer, European Cancer Summit 2022: Establishing a strong patient-physician relationship
View